Complement Component C3 and C4 in Patients COVID-19 Induced Cytokine Released Storm

被引:0
|
作者
Aljwaid, Husam Oudah [1 ]
Ghali, Thamer J. [1 ]
Al-Hisnawi, Ali A. [2 ,3 ]
Abass, Kasim Sakran [4 ]
机构
[1] Natl Univ Sci & Technol, Coll Med Technol, Dept Med Lab Tech, Thi Qar, Iraq
[2] Univ Kerbala, Coll Sci, Dept Biol, Kerbala, Iraq
[3] Univ Kerbala, Coll Sci, Unit Al Razzaza Lake & West Euphrates River, Kerbala, Iraq
[4] Univ Kirkuk, Coll Pharm, Dept Pharmacol & Toxicol, Kirkuk, Iraq
来源
关键词
Complement; Thi-Qar; C3; C4; COVID-19; Cytokine; REACTIVE PROTEIN; RECEPTOR; INTERLEUKIN-6; IL-6;
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Aim: To evolution the complement component C3 and C4 in patients COVID-19 induced cytokine released storm. Methods: The case control study was conducted in Imam AL-Hussain Hospital in Thi-Qar Governorate from February 2020 to September 2020. In our study was forty of them with cytokine storm-induce SARS-COVID 19 depended on clinical feature and lab testing. Hence, fifty persons normally as a control group. The age group between 25 to up to 80 age and both gender included in the current study. Results: The level of IL6 in patients was 107.41 +/- 18.18 Pg/ml, this value showed to be in cytokine storm phenomenon while the control group was 17.41 +/- 5.45 Pg/ml. The differences were highly significant different (P= 0.00). Complement component of C3 and C4 levels of infected patient were (2.47 +/- 0.399) and (0.655 +/- 0.133), respectively showed highly elevated than the normal range. Conclusion: However, ferritin was out of the rang (>2000 ng/mL) and C-reactive protein (CRP) was highly elevated (134.05 +/- 22.67mg/L) showed highly elevated than the normal range. The mean of was ranged interleukin 6 >107.41, ferritin >2000 ng/mL, while, C.R. Protein 134.05mg/L suggested patient with cytokine release storm. However, several anti-cytokine approaches have proven effective in reversing cytokine storm syndromes.
引用
收藏
页码:1211 / 1214
页数:4
相关论文
共 50 条
  • [1] COMPLEMENT COMPONENTS OF C3 AND C4 IN NIGERIANS
    OLUSI, SO
    MCFARLANE, H
    TROPICAL AND GEOGRAPHICAL MEDICINE, 1975, 27 (03): : 262 - 264
  • [2] Elevated levels of C3, C4, and CH50 of the complement system in ICU and non-ICU patients with COVID-19
    Bagherimoghaddam, Ahmad
    Rafatpanah, Houshang
    Mansouritorghabeh, Hassan
    HEALTH SCIENCE REPORTS, 2022, 5 (02)
  • [3] THIRD COMPONENT OF COMPLEMENT (C3) AND FOURTH COMPONENT OF COMPLEMENT (C4) IN DISCOID AND SYSTEMIC LUPUS-ERYTHEMATOSUS
    RISUM, G
    DERMATOLOGICA, 1973, 147 (06): : 381 - 390
  • [4] ASSOCIATIONS BETWEEN SERUM LEVELS OF C3, C4, AND TOTAL CLASSICAL COMPLEMENT ACTIVITY IN COVID-19 PATIENTS AT THE TIME OF ADMISSION AND CLINICAL OUTCOME
    Razi, A.
    Azimian, A.
    Arezumand, R.
    Solati, A.
    Ahmadabad, H. N.
    INFEKTSIYA I IMMUNITET, 2022, 12 (05): : 869 - 874
  • [5] Complement Components, C3 and C4, and the Metabolic Syndrome
    Copenhaver, Melanie
    Yu, Chack-Yung
    Hoffman, Robert P.
    CURRENT DIABETES REVIEWS, 2019, 15 (01) : 44 - 48
  • [6] Complement components (C3, C4) in childhood asthma
    Najam F.I.E.
    Giasuddin A.S.M.
    Shembesh A.H.
    The Indian Journal of Pediatrics, 2005, 72 (9) : 745 - 749
  • [7] Production of the third and fourth component of complement (C3, C4) by smooth muscle cells
    Ueda, Y
    Nagasawa, K
    Tsukamoto, H
    Horiuchi, T
    Nishizaka, H
    Ikeda, K
    Niho, Y
    IMMUNOLOGY, 1996, 89 (02) : 183 - 188
  • [8] 28 ≤ R(C4, C4, C3, C3) ≤ 36
    Xu Xiaodong
    Radziszowski, Stanislaw P.
    UTILITAS MATHEMATICA, 2009, 79 : 253 - 257
  • [9] The early predictive role of complement C3 and C4 in patients with acute pancreatitis
    Zhang, Lifeng
    Qiao, Zhenguo
    Feng, Huang
    Shen, Jiaqing
    JOURNAL OF CLINICAL LABORATORY ANALYSIS, 2020, 34 (05)
  • [10] Effect of weight loss on C3 and C4 components of complement in obese patients
    Hernandez-Mijares, Antonio
    Banuls, Celia
    Bellod, Lorena
    Jover, Ana
    Sola, Eva
    Morillas, Carlos
    Victor, Victor M.
    Rocha, Milagros
    EUROPEAN JOURNAL OF CLINICAL INVESTIGATION, 2012, 42 (05) : 503 - 509